LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Zurück zur letzten Suche Suchhistorie
Erweiterte Suche

Ihre letzten Suchen

  1. AU=Siderowf Andrew
  2. AU="Quesada, Carlos Alberto"
  3. AU="Narges Rasouli"
  4. AU=McCaughan Dorothy
  5. AU="Hasnaoui, Nawal"
  6. AU="Yu, Bingwei"
  7. AU="Alisarli, Mustafa"
  8. AU="Kaufman, Dan"
  9. AU=Weigelin Bettina
  10. AU="Arun Kumar S"
  11. AU="Dahlsjö, Cecilia A L"
  12. AU="Gavigan, Patrick"
  13. AU="Liu, Ye"
  14. AU="Changyang Xing"
  15. AU="Sarovich, Derek S"
  16. AU="Joseph P. Zackular"
  17. AU="Maes, Evelyn"
  18. AU="Haixiang Zhou"
  19. AU="Choi, Jinyong"
  20. AU="González-Mansilla, Ana"
  21. AU="Cho Kilwon"
  22. AU="Rachide Onadja, Palamanga Abdoul"
  23. AU="Bertacca, Sofia"
  24. AU="Bansal, Ayush"
  25. AU="Liao, Naikai"
  26. AU="Gomes, Lux Attiê Santos"
  27. AU="İdil Su Canıtez"
  28. AU="Baptiste Duceau"
  29. AU="Pedro Seoane-Zonjic"
  30. AU="Guthridge, Carla J"
  31. AU=Meena Netra P.
  32. AU="Boustany, Tara"

Suchergebnis

Treffer 1 - 10 von insgesamt 208

Suchoptionen

  1. Artikel ; Online: α-synuclein seed amplification in Parkinson's disease - Authors' reply.

    Siderowf, Andrew / Concha-Marambio, Luis / Marek, Kenneth / Soto, Claudio

    The Lancet. Neurology

    2023  Band 22, Heft 11, Seite(n) 985–986

    Mesh-Begriff(e) Humans ; alpha-Synuclein/genetics ; Parkinson Disease/genetics
    Chemische Substanzen alpha-Synuclein
    Sprache Englisch
    Erscheinungsdatum 2023-10-27
    Erscheinungsland England
    Dokumenttyp Letter ; Comment
    ZDB-ID 2081241-3
    ISSN 1474-4465 ; 1474-4422
    ISSN (online) 1474-4465
    ISSN 1474-4422
    DOI 10.1016/S1474-4422(23)00371-X
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Volltext online

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    Zs.A 5955: Hefte anzeigen Standort:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  2. Artikel: Challenges in the study of individuals at risk for Parkinson disease.

    Marras, Connie / Alcalay, Roy N / Siderowf, Andrew / Postuma, Ronald B

    Handbook of clinical neurology

    2023  Band 192, Seite(n) 219–229

    Abstract: Identifying individuals at high risk for developing neurodegenerative disease opens the possibility of conducting clinical trials that intervene at an earlier stage of neurodegeneration than has been possible to date, and in doing so hopefully improves ... ...

    Abstract Identifying individuals at high risk for developing neurodegenerative disease opens the possibility of conducting clinical trials that intervene at an earlier stage of neurodegeneration than has been possible to date, and in doing so hopefully improves the odds of efficacy for interventions aimed at slowing or stopping the disease process. The long prodromal phase of Parkinson disease presents opportunities and challenges to establishing cohorts of at-risk individuals. Recruiting people with genetic variants conferring increased risk and people with REM sleep behavior disorder currently constitutes the most promising strategies, but multistage screening of the general population may also be feasible capitalizing on known risk factors and prodromal features. This chapter discusses the challenges involved in identifying, recruiting, and retaining these individuals, and provides insights into possible solutions using examples from studies to date.
    Mesh-Begriff(e) Humans ; Parkinson Disease/epidemiology ; Parkinson Disease/genetics ; Parkinson Disease/diagnosis ; Neurodegenerative Diseases/complications ; REM Sleep Behavior Disorder/diagnosis ; REM Sleep Behavior Disorder/epidemiology ; REM Sleep Behavior Disorder/etiology ; Risk Factors
    Sprache Englisch
    Erscheinungsdatum 2023-01-29
    Erscheinungsland Netherlands
    Dokumenttyp Review ; Journal Article
    ISSN 0072-9752
    ISSN 0072-9752
    DOI 10.1016/B978-0-323-85538-9.00014-6
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  3. Artikel ; Online: Outcome Assessment in Parkinson Disease Prevention Trials: Utility of Clinical and Digital Measures.

    Mirelman, Anat / Siderowf, Andrew / Chahine, Lana

    Neurology

    2022  Band 99, Heft 7 Suppl 1, Seite(n) 52–60

    Abstract: Background and objectives: The prodromal phase of Parkinson disease (PD) is accompanied by subtle clinical signs that are not sufficient for diagnosis but could potentially be measured in the context of clinical trials of therapies intended to delay or ... ...

    Abstract Background and objectives: The prodromal phase of Parkinson disease (PD) is accompanied by subtle clinical signs that are not sufficient for diagnosis but could potentially be measured in the context of clinical trials of therapies intended to delay or prevent more definitive clinical features. The objective of this study was to review the available literature on the presence and time course of subtle motor features in prodromal PD in the context of planning for possible clinical trials.
    Methods: We reviewed the available literature based on expert opinion. We considered a range of outcomes including measurement of clinical features, patient-reported outcomes, digital markers, and clinical diagnosis.
    Results: We considered these features and measures in the context of patient stratification, intermediate outcomes, and clinically relevant end points, including phenoconversion.
    Discussion: Substantial progress has been made in understanding how motor features evolve in the period immediately before a PD diagnosis. Digital measures hold substantial progress for measurement precision and may be additionally relevant because they can be used in naturalistic environments outside the clinic. Future studies should focus on advancing digital sensor technology and analysis and developing methods to implement available methods, particularly determination of a clinical diagnosis of PD, in a clinical trial context.
    Mesh-Begriff(e) Biomarkers ; Humans ; Outcome Assessment, Health Care/methods ; Parkinson Disease/complications ; Parkinson Disease/diagnosis ; Parkinson Disease/therapy ; Research Design
    Chemische Substanzen Biomarkers
    Sprache Englisch
    Erscheinungsdatum 2022-05-26
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 207147-2
    ISSN 1526-632X ; 0028-3878
    ISSN (online) 1526-632X
    ISSN 0028-3878
    DOI 10.1212/WNL.0000000000200236
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    Ui II Zs.153: Hefte anzeigen Standort:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)
    Zs.MG 18: Hefte anzeigen
    Zs.MO 374: Hefte anzeigen

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  4. Buch: Treatment strategies and quality of care indicators for patients with Parkinson's disease

    Chen, Jack J. / Lew, Mark F. / Siderowf, Andrew

    (Journal of managed care pharmacy ; 15,3, Suppl.)

    2009  

    Titelvarianten Treatment strategies and quality-of-care indicators for patients with Parkinson's disease
    Verfasserangabe Jack J. Chen ; Mark F. Lew ; Andrew Siderowf
    Serientitel Journal of managed care pharmacy ; 15,3, Suppl.
    Überordnung
    Sprache Englisch
    Umfang S21 S. : graph. Darst.
    Verlag Acad. of Managed Care Pharmacy
    Erscheinungsort Alexandria, VA
    Erscheinungsland Vereinigte Staaten
    Dokumenttyp Buch
    HBZ-ID HT017765220
    Datenquelle Katalog ZB MED Medizin, Gesundheit

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    SignaturLeihstatusStandort
    Zs A 5450 -15,3,Suppl.- nicht ausleihbar Zeitschriften-Lesesaal

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  5. Artikel ; Online: Bridging the credibility gap in cost effectiveness analysis.

    Siderowf, Andrew

    Movement disorders : official journal of the Movement Disorder Society

    2014  Band 29, Heft 2, Seite(n) 164–165

    Mesh-Begriff(e) Cost of Illness ; Cost-Benefit Analysis/economics ; Humans ; Parkinson Disease/economics
    Sprache Englisch
    Erscheinungsdatum 2014-02
    Erscheinungsland United States
    Dokumenttyp Comment ; Editorial
    ZDB-ID 607633-6
    ISSN 1531-8257 ; 0885-3185
    ISSN (online) 1531-8257
    ISSN 0885-3185
    DOI 10.1002/mds.25758
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Volltext online

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    Zs.A 2555: Hefte anzeigen Standort:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)
    Zs.MO 238: Hefte anzeigen

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  6. Artikel ; Online: Biomarkers for atypical Parkinsonism: Some progress, but much work remains.

    Feigin, Andrew / Siderowf, Andrew

    Parkinsonism & related disorders

    2018  Band 48, Seite(n) 1–2

    Mesh-Begriff(e) Biomarkers/metabolism ; Humans ; Parkinsonian Disorders/diagnosis ; Parkinsonian Disorders/metabolism
    Chemische Substanzen Biomarkers
    Sprache Englisch
    Erscheinungsdatum 2018-03-02
    Erscheinungsland England
    Dokumenttyp Editorial
    ZDB-ID 1311489-x
    ISSN 1873-5126 ; 1353-8020
    ISSN (online) 1873-5126
    ISSN 1353-8020
    DOI 10.1016/j.parkreldis.2018.02.025
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Volltext online

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    Zs.A 4553: Hefte anzeigen Standort:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)
    Zs.MO 420: Hefte anzeigen

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  7. Artikel: Predictive value of abbreviated olfactory tests in prodromal Parkinson disease.

    Vaswani, Pavan A / Morley, James F / Jennings, Danna / Siderowf, Andrew / Marek, Kenneth

    NPJ Parkinson's disease

    2023  Band 9, Heft 1, Seite(n) 103

    Abstract: There is disagreement in the literature whether olfaction may show specific impairments in Parkinson Disease (PD) and if olfactory tests comprised of selected odors could be more specific for diagnosis. We sought to validate previously proposed subsets ... ...

    Abstract There is disagreement in the literature whether olfaction may show specific impairments in Parkinson Disease (PD) and if olfactory tests comprised of selected odors could be more specific for diagnosis. We sought to validate previously proposed subsets of the University of Pennsylvania Smell Identification Test (UPSIT) odors for predicting conversion to PD in an independent, prodromal cohort. Conversion to PD was assessed in 229 participants in the Parkinson At Risk Study who completed baseline olfactory testing with the UPSIT and up to 12 years of clinical and imaging evaluations. No commercially available or proposed subset performed better than the full 40-item UPSIT. The proposed "PD-specific" subsets also did not perform better than expected by chance. We did not find evidence for selective olfactory impairment in Parkinson disease. Shorter odor identification tests, including commercially available 10-12 item tests, may have utility for ease of use and cost, but not for superior predictive value.
    Sprache Englisch
    Erscheinungsdatum 2023-06-29
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2819218-7
    ISSN 2373-8057
    ISSN 2373-8057
    DOI 10.1038/s41531-023-00530-z
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  8. Artikel ; Online: Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study.

    Vaswani, Pavan A / Morley, James F / Jennings, Danna / Siderowf, Andrew / Marek, Kenneth

    Parkinsonism & related disorders

    2022  Band 104, Seite(n) 15–20

    Abstract: Background: The Parkinson Associated Risk Syndrome (PARS) study was designed to evaluate whether screening with olfactory testing and dopamine transporter (DAT) imaging could identify participants at risk for developing Parkinson's disease (PD).: ... ...

    Abstract Background: The Parkinson Associated Risk Syndrome (PARS) study was designed to evaluate whether screening with olfactory testing and dopamine transporter (DAT) imaging could identify participants at risk for developing Parkinson's disease (PD).
    Objective: Hyposmia on a single test has been associated with increased risk of PD, but, taken alone, lacks specificity. We evaluated whether repeating olfactory testing improves the diagnostic characteristics of this screening approach.
    Methods: Participants completed up to 10 years of clinical and imaging evaluations in the PARS cohort. Olfaction was assessed with the University of Pennsylvania Smell Identification Test at baseline and on average 1.4 years later. Multiple logistic regression and Cox proportional hazards regression were used to estimate the hazard of development of clinical PD or abnormal DAT imaging.
    Results: Of 186 participants who were initially hyposmic, 28% reverted to normosmia on repeat testing (reverters). No initially normosmic subjects and only 2% of reverters developed DAT imaging progression or clinical PD, compared to 29% of subjects with persistent hyposmia who developed abnormal DAT and 20% who developed clinical PD. The relative risk of clinical conversion to PD was 8.3 (95% CI:0.92-75.2, p = 0.06) and of abnormal DAT scan was 12.5 (2.4-156.2, p = 0.005) for persistent hyposmia, compared to reversion.
    Conclusions: Persistent hyposmia on serial olfactory testing significantly increases the risk of developing clinical PD and abnormal DAT imaging, compared to hyposmia on a single test. Repeat olfactory testing may be an efficient and cost-effective strategy to improve identification of at-risk patients for early diagnosis and disease modification studies.
    Mesh-Begriff(e) Humans ; Parkinson Disease/diagnosis ; Parkinson Disease/diagnostic imaging ; Smell ; Olfaction Disorders/diagnosis ; Olfaction Disorders/etiology ; Anosmia ; Cohort Studies
    Sprache Englisch
    Erscheinungsdatum 2022-09-17
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 1311489-x
    ISSN 1873-5126 ; 1353-8020
    ISSN (online) 1873-5126
    ISSN 1353-8020
    DOI 10.1016/j.parkreldis.2022.09.007
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Volltext online

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    Zs.A 4553: Hefte anzeigen Standort:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)
    Zs.MO 420: Hefte anzeigen

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  9. Artikel ; Online: Proposal for a Biologic Staging System of Parkinson's Disease.

    Chahine, Lana M / Merchant, Kalpana / Siderowf, Andrew / Sherer, Todd / Tanner, Caroline / Marek, Kenneth / Simuni, Tanya

    Journal of Parkinson's disease

    2023  Band 13, Heft 3, Seite(n) 297–309

    Abstract: The Parkinson's disease (PD) research field has seen the advent of several promising biomarkers and a deeper understanding of the clinical features of the disease from the earliest stages of pathology to manifest disease. Despite progress, a biologically ...

    Abstract The Parkinson's disease (PD) research field has seen the advent of several promising biomarkers and a deeper understanding of the clinical features of the disease from the earliest stages of pathology to manifest disease. Despite progress, a biologically based PD staging system does not exist. Such staging would be a useful framework within which to model the disease, develop and validate biomarkers, guide therapeutic development, and inform clinical trials design. We propose that the presence of aggregated neuronal α-synuclein, dopaminergic neuron dysfunction/degeneration, and clinical signs and symptoms identifies a group of individuals that have Lewy body pathology, which in early stages manifests with what is now referred to as prodromal non-motor features and later stages with the manifestations of PD and related Lewy body diseases as defined by clinical diagnostic criteria. Based on the state of the field, we herein propose a definition and staging of PD based on biology. We present the biologic basis for such a staging system and review key assumptions and evidence that support the proposed approach. We identify gaps in knowledge and delineate crucial research priorities that will inform the ultimate integrated biologic staging system for PD.
    Mesh-Begriff(e) Humans ; Parkinson Disease/diagnosis ; Parkinson Disease/pathology ; alpha-Synuclein ; Lewy Body Disease/diagnosis ; Lewy Bodies/pathology ; Nerve Degeneration/pathology ; Biomarkers ; Prodromal Symptoms ; Biological Products
    Chemische Substanzen alpha-Synuclein ; Biomarkers ; Biological Products
    Sprache Englisch
    Erscheinungsdatum 2023-04-17
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2620609-2
    ISSN 1877-718X ; 1877-7171
    ISSN (online) 1877-718X
    ISSN 1877-7171
    DOI 10.3233/JPD-225111
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    Zs.A 6964: Hefte anzeigen Standort:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  10. Artikel: Linked Patient and Provider Impressions of Outpatient Teleneurology Encounters.

    James, Justin G / Park, Jane / Oliver, Alexandria / Xie, Sharon X / Siderowf, Andrew / Spindler, Meredith / Wechsler, Lawrence R / Tropea, Thomas F

    Neurology. Clinical practice

    2023  Band 13, Heft 3, Seite(n) e200159

    Abstract: Background and objectives: Teleneurology is common in clinical practice partly due to the SARS CoV-2 pandemic. Impressions about teleneurology from patients and providers alike are generally favorable; some of the reported benefits include ease of ... ...

    Abstract Background and objectives: Teleneurology is common in clinical practice partly due to the SARS CoV-2 pandemic. Impressions about teleneurology from patients and providers alike are generally favorable; some of the reported benefits include ease of access to specialized health care, savings of time and money, and similar quality of care as an in-person visit. However, comparisons between patient and provider impressions about the same teleneurology encounter have not been described. In this study, we describe patient impressions about a teleneurology encounter and evaluate concordance with provider impressions about the same encounter.
    Methods: Patients and providers at the University of Pennsylvania Hospital Neurology Department were surveyed about their impressions of teleneurology between April 27, 2020, and June 16, 2020. A convenience sample of patients, whose providers completed a questionnaire, were contacted by telephone to solicit their impressions about the same encounter. Unique questionnaires for patients and providers focused on similar themes, such as adequacy of technology, assessment of history obtained, and overall quality of the visit. Summaries of patient responses are reported with the raw percent agreement between patients and providers for similar questions.
    Results: One hundred thirty-seven patients completed the survey; 64 (47%) were male and 73 (53%) were female. Sixty-six (47%) patients had a primary diagnosis of PD, 42 (30%) a non-PD/parkinsonism movement disorder, and 29 (21%) a nonmovement disorder neurologic disease. One hundred one (76%) were established patient visits and 36 (26%) were new patient visits. Provider responses from 8 different physicians were included. Most of the patients responded that the ease of joining their visit, their comfort engaging with their physicians during their visit, understanding their plan of care after their visit, and the quality of care from their teleneurology visit were satisfactory. Patients and providers agreed about their impressions of the quality of the history obtained (87% agreement), patient-provider relationship (88% agreement), and overall quality of their experience (70% agreement).
    Discussion: Patients had favorable impressions about their clinical experience with teleneurology and expressed an interest in incorporating telemedicine visits into their ongoing care. Patients and providers were highly concordant for the history obtained, patient-provider relationship, and overall quality.
    Sprache Englisch
    Erscheinungsdatum 2023-05-01
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2645818-4
    ISSN 2163-0933 ; 2163-0402
    ISSN (online) 2163-0933
    ISSN 2163-0402
    DOI 10.1212/CPJ.0000000000200159
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

Zum Seitenanfang